Eric Boutin Email and Phone Number
Eric Boutin work email
- Valid
- Valid
- Valid
Eric Boutin personal email
- Valid
Eric Boutin phone numbers
Eric Boutin is a digital health investor, board member, and serial entrepreneur, helping early-stage startups to global pharma companies reimagine healthcare through science and technology.Eric helps founders launch, fund, and scale companies through Harvard Street Advising. He was a Venture Chair at Redesign Health, a digital health venture studio, where he created and financed health tech startup companies. Before that, he was a Managing Director at dRx Capital, Novartis’ digital health venture capital fund, where he led early-stage investments in pharma tech, patient care, and healthcare AI.Prior to dRx, Eric was Founder and CEO of Evolve, an AI-powered consumer tech company, which was acquired by HubSpot (NYSE: HUBS). He was Founder and CEO of Good Start Genetics, a reproductive health and genomics company, which was acquired by Invitae (NYSE: NVTA). Eric was also an EIR at Longwood Fund, a life sciences venture capital fund, where he led early-stage biotech deals and founded Flex Pharma, a neuromuscular sports performance company, which went on to IPO (NASDAQ: FLKS).Eric holds an MBA from Harvard Business School and a B.A. in Economics from Duke University. He has held board director or observer roles for Seed through Series D companies in digital health, tech, and life sciences.
-
Venture AdvisorHarvard Street Advising 2018 - PresentCambridge, Ma, UsVenture capital and startup advisory.-----Digital health advisory helping founders launch, fund, and scale companies, and helping investors perform diligence on early-stage deals. Recent work includes: - Harvard Business School, Entrepreneur in Residence, Boston, MA (2024–present)- Stealth Healthcare Venture Studio, Advisor, San Francisco, CA (2024–present)- NextGen Venture Partners, Venture Partner, Boston, MA (2018–present)
-
Venture ChairRedesign Health Jan 2023 - Dec 2023New York, New York, UsDigital health venture studio and seed fund.-----Recruited into a hybrid venture capital / operating partner role—led company creation through thesis development, investment diligence, founding team construction, and CEO mentoring and board governance.Created and funded two companies, including an AI benefits brokerage (Seed) and a concierge longevity platform (Seed). Led teams through diligence on other exploratory concepts including clinical trial retention and patient financial assistance. Served as board director for two additional companies. -
Managing DirectorDrx Capital 2020 - 2023Basel, ChNovartis' digital health venture capital fund.-----Engaged to bring a founder and operator lens to a new corporate venture fund. dRx Capital makes early-stage investments in pharma tech (R&D optimization, drug commercialization), patient care (devices, diagnostics), and AI applications in healthcare. Board observer seats accompany all investments.Invested in Peptone (Seed), Flywheel (Series B), Freenome (Series C), Cala Health (Series D). -
Venture Partner, AdvisorNextgen Venture Partners 2018 - 2019San Francisco, California, UsProfessional sabbatical. Sold Good Start Genetics (NVTA) and Evolve (HUBS) in 2017. Served as Venture Partner for NextGen Venture Partners, Advisor for Inlightened, and Advisor for Nix Biosensors. -
Founder, CeoEvolve App 2015 - 2017Boston, Ma, UsAdvice in Love, powered by AI.-----Founded a consumer-tech company to bring data and self-awareness to romance. Evolve uncovers patterns in a user’s dating history and provides AI-driven relationship advice.Raised Seed round; recruited technical team (e.g., CTO, engineering); managed development and launch of four versions of iOS app; and ran M&A leading to Evolve’s acquisition by Hubspot (NYSE: HUBS) in 2017. -
Investor, EirLongwood Fund 2013 - 2015Boston, Ma, UsLife science venture capital fund.-----Brought on as Longwood’s first EIR, a two-year program with a dual-mandate to evaluate biotech investments and help found and launch a new science-based company.Led early-stage deals in therapeutics, consumer health, and medical devices, including Mitobridge (Series A, acquired), Colorscience (Series B), and Channel Medsystems (Series C, acquired). Founded Flex Pharma (NASDAQ: FLKS), a neuromuscular sports performance company, resulting in a $40M Series A raise, and subsequent $85M IPO in 2015. Shaped product and go-to-market strategy for the sports supplement based on Nobel Prize chemistry, endorsed by NFL, MLB, NBA, and NHL athletes. -
Founder, Ceo & Board Director | Vp Of Business Development | Board ObserverGood Start Genetics 2007 - 2012Cambridge, Ma, UsReproductive health and genomics company.-----Founded, built, launched a molecular diagnostics company based on technology from George Church’s Lab at Harvard Medical School. Commercialized the world’s first clinical application of Next-Gen Sequencing.Good Start Genetics raised $60M in Series A and B financings, grew to $40M in annual revenue, 150 FTEs, and was acquired by Invitae (NYSE: NVTA) in 2017.As Founder and CEO, created IVF go-to-market strategy and product roadmap to commercial the new genomic technology; built and led a ten-member team (e.g., CTO, CMO); and enlisted board directors. Assembled $18M Series A syndicate led by OrbiMed Advisors. Recruited LabCorp’s COO to serve as CEO in 2010. Also, held business development accountability, built clinical advisory board, and ran innovation team.ALL ROLES at GOOD START GENETICS:Board Observer (2010–2017)VP of Business Development (2010–2012)Founder, CEO & Board Director (2007–2010) -
Strategy ConsultantAccenture 2001 - 2005Dublin 2, IeWorked with Fortune 500 companies across healthcare, technology, consumer goods, and retail. Advised senior leaders on strategic initiatives, business development opportunities, and operational efficiencies.BOTH ROLES at ACCENTURE:Strategy Consultant, 2003 to 2005Business Analyst, 2001 to 2003
Eric Boutin Skills
Eric Boutin Education Details
-
Harvard Business SchoolMba -
Duke UniversityEconomics
Frequently Asked Questions about Eric Boutin
What company does Eric Boutin work for?
Eric Boutin works for Harvard Street Advising
What is Eric Boutin's role at the current company?
Eric Boutin's current role is Entrepreneur, Investor, Board Member.
What is Eric Boutin's email address?
Eric Boutin's email address is er****@****ail.com
What is Eric Boutin's direct phone number?
Eric Boutin's direct phone number is +161799*****
What schools did Eric Boutin attend?
Eric Boutin attended Harvard Business School, Duke University.
What are some of Eric Boutin's interests?
Eric Boutin has interest in Arts And Culture.
What skills is Eric Boutin known for?
Eric Boutin has skills like Entrepreneurship, Start Ups, Venture Capital, Healthcare, Strategy, Genetics, Business Development, Angel Investing, Corporate Development, Strategic Partnerships, Business Strategy, Business Planning.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial